In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

superDimension grosses $27mm with Series B round

Executive Summary

Israeli medical device company superDimension Ltd. (focuses on lung diseases) has grossed $27mm with its Series B round led by OrbiMed, which invested $12.5mm and is now the company's largest shareholder. New investors, CIBC World Markets and the strategic investments group of Pfizer, joined most of the company's existing backers, including Oxford Bioscience Partners, Pitango Venture Capital, Medica Venture Partners, and Mi3 Venture Capital.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies